Cargando…

Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records

BACKGROUND: Migraine is a chronic neurological disease causing significant socioeconomic burden and impaired quality of life. Chinese medicine is commonly used for migraine in China. Clinical trials have generated evidence of the effectiveness of Chinese medicine therapies for migraine. However, lit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Shaohua, Zhang, Claire Shuiqing, Sun, Jingbo, Weng, Heng, Xue, Charlie Changli, Guo, Xinfeng, Zhang, Anthony Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684313/
https://www.ncbi.nlm.nih.gov/pubmed/36438031
http://dx.doi.org/10.3389/fmed.2022.936234
_version_ 1784835258175193088
author Lyu, Shaohua
Zhang, Claire Shuiqing
Sun, Jingbo
Weng, Heng
Xue, Charlie Changli
Guo, Xinfeng
Zhang, Anthony Lin
author_facet Lyu, Shaohua
Zhang, Claire Shuiqing
Sun, Jingbo
Weng, Heng
Xue, Charlie Changli
Guo, Xinfeng
Zhang, Anthony Lin
author_sort Lyu, Shaohua
collection PubMed
description BACKGROUND: Migraine is a chronic neurological disease causing significant socioeconomic burden and impaired quality of life. Chinese medicine is commonly used for migraine in China. Clinical trials have generated evidence of the effectiveness of Chinese medicine therapies for migraine. However, little is known about how to use these therapies to treat migraine in real-world clinical settings. METHODS: In this retrospective study, we analyzed data from the electronic medical records (EMRs) of 2,023 migraine patients who attended the Guangdong Provincial Hospital of Chinese Medicine (GPHCM) between July 2018 and July 2020. RESULTS: More than three-quarters (77.21%) of the patients were female. Most (78.20%) of the patients were aged between 18 and 50 years, 18.49% were aged above 50 years, and the remaining 3.31% were under 18 years. Sleep disorders were the most documented comorbidity occurring in 27.29% of patients, and more common in females (29.77%) than male (18.87%). Fatigue was the most frequently reported trigger of migraine attacks among all patients (9.39%), while menstruation was the most common trigger for female patients (10.24%). Less than a quarter of patients (21.01%) reported a history of taking analgesic medication for their migraine. The median treatment duration reported by the patients was 10 days. Chinese herbal medicine (CHM) was the predominant treatment for migraine at the hospital (88.48%), while pharmacotherapies were prescribed to 28.97% of the patients. CHM was prescribed more often as a sole treatment (53.58% of patients) than combined with pharmacotherapies (27.39% of patients). Among patients who reported improvements after taking CHM, the most frequently used herbs were fu ling and chuan xiong, the most frequent patented CHM product was tong tian oral solution, and the main herbal formulae were chuan xiong cha tiao san and yi qi cong ming tang. CONCLUSION: CHM formulae, such as chuan xiong cha tiao san and yi qi cong ming tang, patented CHM product tong tian oral solution, and some herbs are potentially effective treatments for migraine. As such, CHM can be used as an alternative to conventional pharmacotherapies for migraine and is worth further evaluation in randomized controlled trials.
format Online
Article
Text
id pubmed-9684313
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96843132022-11-25 Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records Lyu, Shaohua Zhang, Claire Shuiqing Sun, Jingbo Weng, Heng Xue, Charlie Changli Guo, Xinfeng Zhang, Anthony Lin Front Med (Lausanne) Medicine BACKGROUND: Migraine is a chronic neurological disease causing significant socioeconomic burden and impaired quality of life. Chinese medicine is commonly used for migraine in China. Clinical trials have generated evidence of the effectiveness of Chinese medicine therapies for migraine. However, little is known about how to use these therapies to treat migraine in real-world clinical settings. METHODS: In this retrospective study, we analyzed data from the electronic medical records (EMRs) of 2,023 migraine patients who attended the Guangdong Provincial Hospital of Chinese Medicine (GPHCM) between July 2018 and July 2020. RESULTS: More than three-quarters (77.21%) of the patients were female. Most (78.20%) of the patients were aged between 18 and 50 years, 18.49% were aged above 50 years, and the remaining 3.31% were under 18 years. Sleep disorders were the most documented comorbidity occurring in 27.29% of patients, and more common in females (29.77%) than male (18.87%). Fatigue was the most frequently reported trigger of migraine attacks among all patients (9.39%), while menstruation was the most common trigger for female patients (10.24%). Less than a quarter of patients (21.01%) reported a history of taking analgesic medication for their migraine. The median treatment duration reported by the patients was 10 days. Chinese herbal medicine (CHM) was the predominant treatment for migraine at the hospital (88.48%), while pharmacotherapies were prescribed to 28.97% of the patients. CHM was prescribed more often as a sole treatment (53.58% of patients) than combined with pharmacotherapies (27.39% of patients). Among patients who reported improvements after taking CHM, the most frequently used herbs were fu ling and chuan xiong, the most frequent patented CHM product was tong tian oral solution, and the main herbal formulae were chuan xiong cha tiao san and yi qi cong ming tang. CONCLUSION: CHM formulae, such as chuan xiong cha tiao san and yi qi cong ming tang, patented CHM product tong tian oral solution, and some herbs are potentially effective treatments for migraine. As such, CHM can be used as an alternative to conventional pharmacotherapies for migraine and is worth further evaluation in randomized controlled trials. Frontiers Media S.A. 2022-11-10 /pmc/articles/PMC9684313/ /pubmed/36438031 http://dx.doi.org/10.3389/fmed.2022.936234 Text en Copyright © 2022 Lyu, Zhang, Sun, Weng, Xue, Guo and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Lyu, Shaohua
Zhang, Claire Shuiqing
Sun, Jingbo
Weng, Heng
Xue, Charlie Changli
Guo, Xinfeng
Zhang, Anthony Lin
Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records
title Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records
title_full Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records
title_fullStr Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records
title_full_unstemmed Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records
title_short Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records
title_sort chinese herbal medicine for migraine management: a hospital-based retrospective analysis of electronic medical records
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684313/
https://www.ncbi.nlm.nih.gov/pubmed/36438031
http://dx.doi.org/10.3389/fmed.2022.936234
work_keys_str_mv AT lyushaohua chineseherbalmedicineformigrainemanagementahospitalbasedretrospectiveanalysisofelectronicmedicalrecords
AT zhangclaireshuiqing chineseherbalmedicineformigrainemanagementahospitalbasedretrospectiveanalysisofelectronicmedicalrecords
AT sunjingbo chineseherbalmedicineformigrainemanagementahospitalbasedretrospectiveanalysisofelectronicmedicalrecords
AT wengheng chineseherbalmedicineformigrainemanagementahospitalbasedretrospectiveanalysisofelectronicmedicalrecords
AT xuecharliechangli chineseherbalmedicineformigrainemanagementahospitalbasedretrospectiveanalysisofelectronicmedicalrecords
AT guoxinfeng chineseherbalmedicineformigrainemanagementahospitalbasedretrospectiveanalysisofelectronicmedicalrecords
AT zhanganthonylin chineseherbalmedicineformigrainemanagementahospitalbasedretrospectiveanalysisofelectronicmedicalrecords